McKesson releases new edition of InterQual decision-support system

McKesson Health Solutions unveiled the latest edition of InterQual, the company's flagship decision-support software and technology system, on Monday.
     
The 2015 edition includes 55 new and enhanced evidence-based clinical content areas and extensive updates, including the first admissions criteria to include comorbidities, criteria for 29 new specialty drugs and 33 new molecular diagnostic tests, as well as support for gene panels, among other features.

“There is tremendous variation in care and cost in health care, and the shift to value-based models is increasing the focus on cost and outcomes,” Dr. Jackie Mitus, senior vice president and general manager of decision management for McKesson Health Solutions, said.

InterQual 2015’s evidence-based criteria help in refining clinical decision making across the care spectrum. The InterQual clinical development team produces the most up-to-date evidence into a referenced decision-support tool that is reviewed and updated annually.

InterQual 2015’s Acute Adult Level of Care Criteria promotes quality care and reduces administrative delays, costs and inefficiencies in medical-director reviews.


“With InterQual 2015, we’re helping ensure payers and providers have the evidence-based content they need for the challenges they face today — such as the increase in patients with comorbidities — so they can ensure the most appropriate decisions and highest-quality care,” Mitus said.

For more information, visit Interqual2015.com.